RecruitingNCT06033807
Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
Studying Tuberculosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Huashan Hospital
- Principal Investigator
- Wenhong Zhang, PhDHuashan Hospital
- Intervention
- QuantiFERON-TB Gold (QFT) test(diagnostic_test)
- Enrollment
- 31440 enrolled
- Eligibility
- 13 years · All sexes
- Timeline
- 2023 – 2025
Study locations (30)
- Xinpu New Area Center of Disease Control, Zunyi, Guiyang, China
- Dafang Center for Disease Control and Prevention, Bijie, Guizhou, China
- Qixingguan Center for Disease Control and Prevention, Bijie, Guizhou, China
- Nayong Center for Disease Control and Prevention, Bijie, Guizhou, China
- Hezhang Center for Disease Control, Bijie, Guizhou, China
- Jinsha Center for Disease Control, Bijie, Guizhou, China
- Qianxi Center of Disease Control, Bijie, Guizhou, China
- Weining Center of Disease Control, Bijie, Guizhou, China
- Zhijin Center of Disease Control, Bijie, Guizhou, China
- Liping Center for Disease Control and Prevention, Linping, Guizhou, China
- Liuzhi Special District Center of Disease Control, Liupanshui, Guizhou, China
- Panzhou Center of Disease Control, Liupanshui, Guizhou, China
- Shuicheng District Center of Disease Control, Liupanshui, Guizhou, China
- Cengong Center of Disease Control, Qiandongnan Miao and Dong Autonomous Prefecture, Guizhou, China
- Congjiang Ceter of Disease Control, Qiandongnan Miao and Dong Autonomous Prefecture, Guizhou, China
- +15 more locations on ClinicalTrials.gov
Collaborators
Guizhou Center for Disease Control and Prevention
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06033807 on ClinicalTrials.govOther trials for Tuberculosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07164742Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)Johns Hopkins University
- RECRUITINGNCT0707721318F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis PatientsChildren's Hospital Medical Center, Cincinnati
- ENROLLING BY INVITATIONNANCT06984887Evaluation of New TB Diagnostic Tests (NATs) in PakistanMercy Corps Pakistan
- RECRUITINGNCT07018076Candidate Clinical Correlate of Prognostic Outcome for TB StudyUniversity of California, San Francisco
- RECRUITINGNANCT07271225Safety and Efficacy of Ear Acupuncture for Antituberculosis Drug-Related Nausea and VomitingIndonesia University
- RECRUITINGNCT06585358DoseTB-individualised Dosing by Model-informed Precision Dosing for Pulmonary TuberculosisKarolinska Institutet
- RECRUITINGPHASE3NCT06497465Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB TreatmentJohns Hopkins University
- RECRUITINGNCT07178860Respiratory Health and Wellbeing Post Pulmonary TuberculosisLiverpool School of Tropical Medicine